PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 18 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Extracts showed antibacterial activity, particularly against gram-positive bacteria and Pseudomonas aeruginosa [PMID:10722206, 11891091].
A CHCl(3)-MeOH extract of leaves demonstrated anti-inflammatory activity in a carrageenan-induced rat paw model [PMID:15043416].
Acetonic extract of leaves (100 mg/kg) induced a significant decrease of blood glucose in normoglycaemic rats [PMID:15763379].
Lipophilic extracts from aerial parts showed activity against both chloroquine-sensitive (PoW) and chloroquine-resistant (Dd2) strains in vitro [PMID:12601673].
Aqueous extracts inhibited Toxoplasma growth (IC50 of 16.3 mg/L), with higher activity seen in organic solvent extracts (IC50 as low as 1.7 mg/L) [PMID:10743641].
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 10722206 (2000) — Zulu medicinal plants with antibacterial activity. · Journal of ethnopharmacology
- 2.PMID: 15043416 (2004) — New compounds from an extract of Vernonia colorata leaves with anti-inflammatory activity. · Journal of natural products
- 3.PMID: 12601673 (2003) — In vitro antiplasmodial evaluation of medicinal plants from Zimbabwe. · Phytotherapy research : PTR
- 4.PMID: 15763379 (2005) — Hypoglycaemic and antidiabetic activity of acetonic extract of Vernonia colorata leaves in normoglycaemic and alloxan-induced diabetic rats. · Journal of ethnopharmacology
- 5.PMID: 11891091 (2002) — Isolation and identification of antibacterial compounds from Vernonia colorata leaves.